Avertix Heart Attack Care: Real-Time Monitoring and Medication Adjustments
By Daniella Parra
Avertix Medical presented new data regarding its Guardian System, which can detect heart attacks in real-time and alert high-risk patients, at the Transcatheter Cardiovascular Therapeutics (TCT) conference, the company said.
Avertix said it showed a 150% increase in medication adjustments related to heart rate and rhythm irregularities for patients using the system, the company said.
The study, called the ALERTS Trial, focused on ACS patients and evaluated the Guardian System’s safety and effectiveness, which contributed to better long-term outcomes and care for high-risk heart attack survivors, it said.
“This data has provided us with valuable insights into addressing the care needs of high-risk Acute Coronary Syndrome (ACS) patients,” Dr. Kaplan, M.D., FACC, FHRS, and electrophysiologist, said. “Our findings demonstrate that the use of the Guardian System, with its continuous intracardiac monitoring and patient-alerting capabilities, offers physicians a powerful tool to proactively manage cardiac events, enabling appropriate medication management as part of providing responsive, long-term care.”
Contact:
Editor@Executives-edge.com
